[
  {
    "row_id": "LBA56",
    "regimen": "Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab",
    "drugs": [
      "pembrolizumab"
    ],
    "modality": [
      "IO",
      "Adjuvant"
    ],
    "population": "Other",
    "line": "Adjuvant",
    "phase": "Phase 3",
    "trial_id": "EA6174",
    "biomarkers": []
  },
  {
    "row_id": "1669P",
    "population": "Other",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "1670P",
    "population": "Other",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "1739eTiP",
    "regimen": "Chemio-immunotherapy in naive advanced Merkel cell carcinoma",
    "modality": [
      "IO",
      "Chemotherapy"
    ],
    "population": "Other",
    "line": "Not specified",
    "phase": "Phase 2",
    "trial_id": "PANDORA",
    "drugs": [],
    "biomarkers": []
  }
]